CMRX stock forecast
Our latest prediction for Chimerix, Inc.'s stock price was made on the May 20, 2019 when the stock price was at 3.41$.
In the short term (2weeks), CMRX's stock price should outperform the market by 7.03%. During that period the price should oscillate between -9.88% and +17.57%.
In the medium term (3months), CMRX's stock price should outperform the market by 5.50%. During that period the price should oscillate between -21.18% and +39.38%.Get email alerts
About Chimerix, Inc.
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.
At the moment the company generates 11M USD in revenues.
On its last earning announcement, the company reported a loss of -2.33$ per share.
The book value per share is 3.99$
Three months stock forecastMay 20, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|